Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award-PA: Ionizing Radiation - Medical Uses and Health Effects

University of British Columbia

$0.00

Identification of synthetic cytotoxic interactions to improve the efficacy of DNA damaging therapeutic agents

FY 2011-12

Summary
Many anti-cancer therapies, such as ionization radiation, work by damaging DNA. Cancer cells are often more sensitive to DNA damage than normal cells because they divide faster than normal cells. However, DNA damaging therapies can also have toxic side effects in normal cells (eg. causing hair loss, fatigue). Tumours can also develop resistance to therapeutic treatment. The aim of my project is to identify conditions that better sensitize cancer cells to DNA damaging therapies and reduce side efffects. Certain conditions of cancer drugs may be able to overcome resistance. Other drug conditions may make tumour cells more sensitive to DNA damage and allow for lower doses, which would reduce side effects. There are tens of thousands of possible combinations of drug therapies that need to be screened to identify effective combinations. In my project, I am using a simple model organism, yeast, to test thousands of possible drug and DNA damaging therapy combinations to identify which are effective in killing cells with gene defects found specifically in tumours. In the next step, I am going to test the handful of successful combinations of drugs and DNA damaging therapy (discovered in yeast) on human cells to identify effective combinations that may be useful in treating cancer cells
Program
Doctoral Research Award-PA: Ionizing Radiation - Medical Uses and Health Effects
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
245858
Name
Moshgabadi Noushin
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Nuclear Safety Commission (Ottawa, Ontario)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of synthetic cytotoxic interactions to improve the efficacy of DNA damaging therapeutic agents
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$0
Cihrequipment2
$0
Programname2
Doctoral Research Award-PA: Ionizing Radiation - Medical Uses and Health Effects
Keyworddelim
Cancer; Cancer Somatic Mutations; Cancer Therapy; Dna Damaging Therapeutic Agents; Dna Repair Enzymes; Ionization Radiation; Mammalian Cell Culture; Saccharomyces Cerevisiae; Sirna; Synthetic Cytotoxic Interactions
Abstract
Many anti-cancer therapies, such as ionization radiation, work by damaging DNA. Cancer cells are often more sensitive to DNA damage than normal cells because they divide faster than normal cells. However, DNA damaging therapies can also have toxic side effects in normal cells (eg. causing hair loss, fatigue). Tumours can also develop resistance to therapeutic treatment. The aim of my project is to identify conditions that better sensitize cancer cells to DNA damaging therapies and reduce side efffects. Certain conditions of cancer drugs may be able to overcome resistance. Other drug conditions may make tumour cells more sensitive to DNA damage and allow for lower doses, which would reduce side effects. There are tens of thousands of possible combinations of drug therapies that need to be screened to identify effective combinations. In my project, I am using a simple model organism, yeast, to test thousands of possible drug and DNA damaging therapy combinations to identify which are effective in killing cells with gene defects found specifically in tumours. In the next step, I am going to test the handful of successful combinations of drugs and DNA damaging therapy (discovered in yeast) on human cells to identify effective combinations that may be useful in treating cancer cells
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Moshgabadi, Noushin
Approvedterm
3 ans 0 mois
University of British Columbia - $0 Grant (2011-12) | Canada Spends